Insights

Innovative Technology Longevity InTime BioTech utilizes proprietary causal AI to simulate clinical trials, enabling clients to reduce time and costs associated with bringing aging therapies to market. This advanced platform offers a compelling value proposition for biotech companies seeking faster and more cost-effective regulatory approval processes.

Market Expansion With a focus on building the first generation of approved aging treatments and a broad biotech ecosystem, the company presents opportunities to collaborate on scaling AI-driven trial simulations and developing new therapies in longevity and age-related diseases.

Funding and Growth Although the company's current funding is modest at $100K, its substantial revenue estimate of up to fifty million dollars indicates strong market demand. This growth potential makes Longevity InTime BioTech an attractive partner or client for firms looking to innovate in clinical trial solutions.

Digital Infrastructure Using a modern tech stack including Python, Django, and PWA, the company is well-positioned for scalable, secure, and efficient deployment of its simulation platform, providing opportunities for tech providers or integrators to offer complementary digital solutions.

Industry Positioning As a specialist in aging and longevity biotech trials with patent-pending methods, Longevity InTime BioTech is positioned as a leader in the emerging aging treatment market, making it a prime candidate for strategic partnerships, investments, or client collaborations in the biotech innovation space.

Similar companies to Longevity InTime BioTech

Longevity InTime BioTech Tech Stack

Longevity InTime BioTech uses 8 technology products and services including Linkedin Insight Tag, VK Pixel, Calendly, and more. Explore Longevity InTime BioTech's tech stack below.

  • Linkedin Insight Tag
    Analytics
  • VK Pixel
    Analytics
  • Calendly
    Appointment Scheduling
  • PWA
    Miscellaneous
  • Vercel
    Platform As A Service
  • Python
    Programming Languages
  • HSTS
    Security
  • Django
    Web Frameworks

Media & News

Longevity InTime BioTech's Email Address Formats

Longevity InTime BioTech uses at least 2 format(s):
Longevity InTime BioTech Email FormatsExamplePercentage
First@intime.digitalJohn@intime.digital
50%
Last@intime.digitalDoe@intime.digital
50%

Frequently Asked Questions

Where is Longevity InTime BioTech's headquarters located?

Minus sign iconPlus sign icon
Longevity InTime BioTech's main headquarters is located at Wilmington, Delaware 19801 United States. The company has employees across 5 continents, including AsiaEuropeAfrica.

What is Longevity InTime BioTech's official website and social media links?

Minus sign iconPlus sign icon
Longevity InTime BioTech's official website is longevityintime.org and has social profiles on LinkedInCrunchbase.

What is Longevity InTime BioTech's SIC code NAICS code?

Minus sign iconPlus sign icon
Longevity InTime BioTech's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Longevity InTime BioTech have currently?

Minus sign iconPlus sign icon
As of February 2026, Longevity InTime BioTech has approximately 18 employees across 5 continents, including AsiaEuropeAfrica. Key team members include Independent Owner: O. T.Aws Devops Engineer: A. Y.. Explore Longevity InTime BioTech's employee directory with LeadIQ.

What industry does Longevity InTime BioTech belong to?

Minus sign iconPlus sign icon
Longevity InTime BioTech operates in the Biotechnology Research industry.

What technology does Longevity InTime BioTech use?

Minus sign iconPlus sign icon
Longevity InTime BioTech's tech stack includes Linkedin Insight TagVK PixelCalendlyPWAVercelPythonHSTSDjango.

What is Longevity InTime BioTech's email format?

Minus sign iconPlus sign icon
Longevity InTime BioTech's email format typically follows the pattern of First@intime.digital. Find more Longevity InTime BioTech email formats with LeadIQ.

How much funding has Longevity InTime BioTech raised to date?

Minus sign iconPlus sign icon
As of February 2026, Longevity InTime BioTech has raised $100K in funding. The last funding round occurred on Jan 22, 2020 for $100K.

When was Longevity InTime BioTech founded?

Minus sign iconPlus sign icon
Longevity InTime BioTech was founded in 2018.

Longevity InTime BioTech

Biotechnology ResearchDelaware, United States11-50 Employees

Longevity InTime BioTech developed clinical trials Ai simulations.

We are building the cheat‑secure clinical trial simulation platform to turn breakthroughs like hers into approved therapies, faster. 

We simulate 500+ blinded trials so longevity biotechs can de‑risk human trials and accelerate FDA approval. We're raising to scale the platform that will power the first generation of approved aging treatments.

We simulate clinical trials using causal AI, enabling biotechs to design optimal trials, predict success rates, and slash regulatory risk—turning aging breakthroughs into approved therapies 10x faster & cheaper.  

Other verticals include: diseases prediction methods, structuring instructed medical data.

All methods are proprietary and patent pending. The patents priority is earlier than any other in the same field.

Building Longevity Ecosystem.

Section iconCompany Overview

Headquarters
Wilmington, Delaware 19801 United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $100K

    Longevity InTime BioTech has raised a total of $100K of funding over 3 rounds. Their latest funding round was raised on Jan 22, 2020 in the amount of $100K.

  • $25M$50M

    Longevity InTime BioTech's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $100K

    Longevity InTime BioTech has raised a total of $100K of funding over 3 rounds. Their latest funding round was raised on Jan 22, 2020 in the amount of $100K.

  • $25M$50M

    Longevity InTime BioTech's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.